 
 Check-Cap Ltd.
NASDAQ:CHEK
Overview | Financials
 | Company Name | Check-Cap Ltd. | 
| Symbol | CHEK | 
| Currency | USD | 
| Price | 0.68 | 
| Market Cap | 3,977,660 | 
| Dividend Yield | 0% | 
| 52-week-range | 0.56 - 3.04 | 
| Industry | Diagnostics & Research | 
| Sector | Healthcare | 
| CEO | Mr. Alex Ovadia | 
| Website | https://www.check-cap.com | 
An error occurred while fetching data.
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for 
 Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD





